| 1例COVID-19合并抑郁症患者的药物治疗评价与药学监护 |
| |
| 引用本文： | 熊堉,边原,唐曦婷,童荣生,崔小娇,蒋敏,杨志勇.1例COVID-19合并抑郁症患者的药物治疗评价与药学监护[J].今日药学,2021,31(1):65-68. |
| |
| 作者姓名： | 熊堉 边原 唐曦婷 童荣生 崔小娇 蒋敏 杨志勇 |
| |
| 作者单位： | 四川省医学科学院/四川省人民医院/电子科技大学附属医院药学部,个体化药物治疗四川省重点实验室,四川成都610072;电子科技大学医学院,四川成都600054;甘孜州人民医院药剂科,四川康定626000;四川省医学科学院/四川省人民医院/电子科技大学附属医院药学部,个体化药物治疗四川省重点实验室,四川成都610072 |
| |
| 基金项目： | 国家临床重点专科建设项目(30305030698);四川省省级公益性科研院所基本科研业务专项课题(2018YSKY0017);四川省人民医院院级科研基金临床研究及转化项目(2018LY09)。 |
| |
| 摘 要： | 目的为临床药师参与COVID-19合并抑郁症患者的药学监护提供参考。方法:临床药师参与了1例COVID-19合并抑郁症患者的治疗过程,优化治疗方案并提供全程化的药学监护。结果:此例患者在新冠肺炎治疗期间,因病情复杂,合并用药种类较多,在治疗过程中出现癫痫发作,药疹及肝功能异常,临床药师经过药物治疗分析和评价之后,为临床医生提供相应的调整策略,并实施全程化的药学监护。最终,患者感染等症状控制,治愈出院。结论:临床药师能在COVID-19患者治疗的过程中协助临床医师不断优化调整方案,为患者的治疗起到积极的作用。
|
| 关 键 词： | 新型冠状病毒肺炎 抑郁症 临床药师 药物治疗评价 药学监护 |
Evaluation of Drug Therapy and Pharmaceutical Care in A Patient with COVID-19 and Depression |
| |
| XIONG Yu,BIAN Yuan,TANG Xiting,TONG Rongsheng,CUI XiaojiaoJIANG Min,YANG Zhiyong.Evaluation of Drug Therapy and Pharmaceutical Care in A Patient with COVID-19 and Depression[J].Pharmacy Today,2021,31(1):65-68. |
| |
| Authors: | XIONG Yu BIAN Yuan TANG Xiting TONG Rongsheng CUI XiaojiaoJIANG Min YANG Zhiyong |
| |
| Institution: | (Personalized Drug Therapy Key Laboratory of Sichuan Province,Department of Pharmacy Sichuan Academy of Medical Sciences,Sichuan Provincial People’s Hospital,Affiliated Hospital of University of Electronic Science and Technology of China,Chengdu,Sichuan 610072,China;School of Medicine,University of Electronic Science and Technology of China,Chengdu,Sichuan 610054,China;Department of Pharmacy,Garui Tibetan autonomous prefecture people's hospital,Kangding,Sichuan 626000,China) |
| |
| Abstract: | OBJECTIVE To provide a reference for clinical pharmacists participating in the pharmaceutical monitoring of a COVID-19 patient with depression. METHODS The clinical pharmacist participated in the treatment of a COVID-19 patient with depression,optimized the treatment plan and provided full-course pharmaceutical monitoring. RESULTS During the treatment of COVID-19 in this patient,due to the complicated condition and many types of combined medication,seizures,drug eruptions and abnormal liver function were occurred during the treatment. After the analysis and evaluation of the drug treatment,the clinical pharmacists provided corresponding adjustment strategies for the clinicians and implemented a full-course pharmaceutical supervision.Eventually,infection and other symptoms of the patient were controlled and cured. CONCLUSION Clinical pharmacists can assist clinicians in continuously optimizing and adjusting programs during the treatment of COVID-19 to patients,and play a positive role in the treatment of patients. |
| |
| Keywords: | COVID-19 depressive disorder clinical pharmacists drug treatment evaluation pharmaceutical care |
| 本文献已被 维普 万方数据 等数据库收录！ |
|
